A new study reveals how chronic psychological stress affects heart attack outcomes, using a rat model to observe damage over ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Pneumonia, frequently intertwined with cardiovascular disease, escalates the risk of heart complications like heart attacks ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

A history of HDP is linked to increased risks of myocardial infarction, whether that’s with obstructive ... conditions that ...

In a recent study published in Nature, researchers examine how sleep impacts inflammation and recovery following a heart ...

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational ... In LODOCO2, which randomized 5522 patients ...

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...